China’s National Health Commission has said that Aluvia, which is designed to treat HIV, is a possible treatment for the symptoms of the coronavirus. Aluvia works by blocking an enzyme that the coronavirus needs to reproduce.
One coronavirus patient told China’s Time-Weekly that Aluvia seemed to be effective for him, according to Endpoints News.
Aluvia has previously been tested in patients with SARS and MERS, other types of coronaviruses.
However, Aluvia is hard to get in China, a Wuhan physician told Time-Weekly.
In response, AbbVie said it will donate $1.44 million worth of the pills, but didn’t specify how it would distribute them, Endpoints News reported.
Read the full article here.
More articles on pharmacy:
BCBS, Civica Rx create subsidiary to cut generic drug costs
PhRMA spent a record $29M on lobbying in 2019
Former Insys CEO gets 30 months in prison
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
